Mirum est notare quam littera gothica, quam nunc putamus parum claram, anteposuerit litterarum formas humanitatis per seacula quarta decima et quinta decima. Eodem modo typi, qui nunc nobis videntur parum clari, fiant sollemnes in futurum.
Nancy M. Holekamp, MD was Director of Retina Services at the Pepose Vision Institute in St. Louis, Missouri from 2011 to 2022. Prior, she was Professor of Clinical Ophthalmology at the Washington University School of Medicine in St. Louis, Missouri from 2009 to 2020. She has been a principal investigator in more than 40 national clinical trials dealing with age-related macular degeneration, retinal vascular occlusion, and diabetic retinopathy. Her efforts in research have resulted in over 100 peer-reviewed publications, 22 book chapters, and more than 150 speaking invitations. She was Visiting Professor at Roche in 2023 and is now a Principal Global Medical Science Lead at Roche co-leading the amdARRAY, a global collaborative research network focused on a better understanding of AMD.
Mirum est notare quam littera gothica, quam nunc putamus parum claram, anteposuerit litterarum formas humanitatis per seacula quarta decima et quinta decima. Eodem modo typi, qui nunc nobis videntur parum clari, fiant sollemnes in futurum.